Chemotherapy-induced acute kidney injury: epidemiology, pathophysiology, and therapeutic approaches
Frontiers in Nephrology · 09.08.2024 · 4
DOI: 10.3389/fneph.2024.1436896 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Nephrology, online erschienen am 09.08.2024. Verfasst von Rafaella Maria da Cunha Lyrio und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Universidade Salvador (UNIFACS), Salvador, Brazil. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 255 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Despite significant advancements in oncology, conventional chemotherapy remains the primary treatment for diverse malignancies. Acute kidney injury (AKI) stands out as one of the most prevalent and severe adverse effects associated with these cytotoxic agents. While platinum compounds are well-known for their nephrotoxic potential, other drugs including antimetabolites, alkylating agents, and antitumor antibiotics are also associated. The onset of AKI poses substantial risks, including heightened morbidity and mortality rates, prolonged hospital stays, treatment interruptions, and the need for renal replacement therapy, all of which impede optimal patient care. Various proactive measures, such as aggressive hydration and diuresis, have been identified as potential strategies to mitigate AKI; however, preventing its occurrence during chemotherapy remains challenging. Additionally, several factors, including intravascular volume depletion, sepsis, exposure to other nephrotoxic agents, tumor lysis syndrome, and direct damage from cancer’s pathophysiology, frequently contribute to or exacerbate kidney injury. This article aims to comprehensively review the epidemiology, mechanisms of injury, diagnosis, treatment options, and prevention strategies for AKI induced by conventional chemotherapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Universidade Salvador (UNIFACS), Salvador, Brazil.
- Hematology Department, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil.
Zitieren
APA
Lyrio, R. M. D. C., Rocha, B. R. A., Corrêa, A. L. R. M., Mascarenhas, M. G. S., Santos, F. L., Maia, R. D. H., Segundo, L. B., de Almeida, P. A. A., Moreira, C. M. O., & Sassi, R. H. (2024). Chemotherapy-induced acute kidney injury: epidemiology, pathophysiology, and therapeutic approaches. Frontiers in Nephrology, 4. https://doi.org/10.3389/fneph.2024.1436896
Vancouver
Lyrio RMDC, Rocha BRA, Corrêa ALRM, Mascarenhas MGS, Santos FL, Maia RDH, et al. Chemotherapy-induced acute kidney injury: epidemiology, pathophysiology, and therapeutic approaches. Frontiers in Nephrology. 2024;4. doi:10.3389/fneph.2024.1436896
BibTeX
@article{Lyrio2024,
author = {Lyrio, Rafaella Maria da Cunha and Rocha, Bruna Reis Araújo and Corrêa, Ana Luiza Rodrigues Mascarenhas and Mascarenhas, Maria Gabriela Santana and Santos, Felipe Luz and Maia, Rafael da Hora and Segundo, Lívia Benezath and de Almeida, Paulo André Abreu and Moreira, Clara Magalhães Oliveira and Sassi, Rafael Hennemann},
title = {Chemotherapy-induced acute kidney injury: epidemiology, pathophysiology, and therapeutic approaches},
journal = {Frontiers in Nephrology},
year = {2024},
volume = {4},
doi = {10.3389/fneph.2024.1436896}
}
EUVIMED